Type 1 diabetes mellitus (T1DM) has transitioned from a condition defined by survival-oriented insulin replacement to one increasingly shaped by precision medicine, digital integration, and immune-targeted innovation. While insulin remains indispensable, recent medical advances aim to reduce disease burden, improve glycemic stability, and address t
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes
Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes
Autoimmune Hepatitis in Girl with T1DM
1156 Reached2 Comments4 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes